281 related articles for article (PubMed ID: 33252452)
21. Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin- induced migraine: role of pituitary adenylate cyclase-activating polypeptide.
Farajdokht F; Babri S; Karimi P; Alipour MR; Bughchechi R; Mohaddes G
Eur J Neurosci; 2017 Mar; 45(6):763-772. PubMed ID: 27886414
[TBL] [Abstract][Full Text] [Related]
22. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons.
Mulder H; Uddman R; Moller K; Zhang YZ; Ekblad E; Alumets J; Sundler F
Neuroscience; 1994 Nov; 63(1):307-12. PubMed ID: 7898655
[TBL] [Abstract][Full Text] [Related]
23. Localization of the neuropeptides pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal peptide, and their receptors in the basal brain blood vessels and trigeminal ganglion of the mouse CNS; an immunohistochemical study.
Lund AM; Hannibal J
Front Neuroanat; 2022; 16():991403. PubMed ID: 36387999
[TBL] [Abstract][Full Text] [Related]
24. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
Liu J; Wang G; Dan Y; Liu X
J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
[TBL] [Abstract][Full Text] [Related]
25. Expression and function of calcitonin gene-related peptide (CGRP) receptors in trigeminal ganglia of R192Q Cacna1a knock-in mice.
Vilotti S; Vana N; Van den Maagdenberg AM; Nistri A
Neurosci Lett; 2016 May; 620():104-10. PubMed ID: 27021026
[TBL] [Abstract][Full Text] [Related]
26. Fenofibrate ameliorates nitroglycerin-induced migraine in rats: Role of CGRP/p-CREB/P2X3 and NGF/PKC/ASIC3 signaling pathways.
Ruby HA; Sayed RH; Khattab MA; Sallam NA; Kenway SA
Eur J Pharmacol; 2024 Aug; 976():176667. PubMed ID: 38795754
[TBL] [Abstract][Full Text] [Related]
27. Pituitary adenylate cyclase-activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro.
Lioudyno M; Skoglösa Y; Takei N; Lindholm D
J Neurosci Res; 1998 Jan; 51(2):243-56. PubMed ID: 9469578
[TBL] [Abstract][Full Text] [Related]
28. Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice.
Markovics A; Kormos V; Gaszner B; Lashgarara A; Szoke E; Sandor K; Szabadfi K; Tuka B; Tajti J; Szolcsanyi J; Pinter E; Hashimoto H; Kun J; Reglodi D; Helyes Z
Neurobiol Dis; 2012 Jan; 45(1):633-44. PubMed ID: 22033344
[TBL] [Abstract][Full Text] [Related]
29. Serum CGRP, VIP, and PACAP usefulness in migraine: a case-control study in chronic migraine patients in real clinical practice.
Pérez-Pereda S; Toriello-Suárez M; Ocejo-Vinyals G; Guiral-Foz S; Castillo-Obeso J; Montes-Gómez S; Martínez-Nieto RM; Iglesias F; González-Quintanilla V; Oterino A
Mol Biol Rep; 2020 Sep; 47(9):7125-7138. PubMed ID: 32951099
[TBL] [Abstract][Full Text] [Related]
30. PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine.
Guo S; Ernstsen C; Hay-Schmidt A; Kristensen DM; Ashina M; Olesen J; Christensen SL
J Headache Pain; 2022 Dec; 23(1):155. PubMed ID: 36471250
[TBL] [Abstract][Full Text] [Related]
31. CGRP and migraine: could PACAP play a role too?
Kaiser EA; Russo AF
Neuropeptides; 2013 Dec; 47(6):451-61. PubMed ID: 24210136
[TBL] [Abstract][Full Text] [Related]
32. Distribution and effects of pituitary adenylate cyclase-activating peptide in the rabbit eye.
Wang ZY; Alm P; Håkanson R
Neuroscience; 1995 Nov; 69(1):297-308. PubMed ID: 8637627
[TBL] [Abstract][Full Text] [Related]
33. Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention.
Pellesi L; Ashina M; Martelletti P
Expert Opin Emerg Drugs; 2024 Mar; 29(1):57-64. PubMed ID: 38337150
[TBL] [Abstract][Full Text] [Related]
34. High plasma calcitonin gene-related peptide and serum pituitary adenylate cyclase-activating polypeptide levels in patients with neuropathic pain.
Yevgi R; Laloğlu E; Bilge N
Rev Neurol (Paris); 2023 Apr; 179(4):289-296. PubMed ID: 36754669
[TBL] [Abstract][Full Text] [Related]
35. The PACAP receptor: a novel target for migraine treatment.
Schytz HW; Olesen J; Ashina M
Neurotherapeutics; 2010 Apr; 7(2):191-6. PubMed ID: 20430318
[TBL] [Abstract][Full Text] [Related]
36. Calcitonin Gene-Related Peptide (CGRP) and Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in Migraine Pathogenesis.
Christensen CE; Ashina M; Amin FM
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297301
[TBL] [Abstract][Full Text] [Related]
37. Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders.
Karsan N; Edvinsson L; Vecsei L; Goadsby PJ
Ann Clin Transl Neurol; 2024 Jun; ():. PubMed ID: 38887982
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets.
Haanes KA; Edvinsson L
CNS Drugs; 2019 Jun; 33(6):525-537. PubMed ID: 30989485
[TBL] [Abstract][Full Text] [Related]
39. Calcitonin Gene-Related Peptide mRNA Synthesis in Trigeminal Ganglion Neurons after Cortical Spreading Depolarization.
Shibata M; Kitagawa S; Unekawa M; Takizawa T; Nakahara J
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511336
[TBL] [Abstract][Full Text] [Related]
40. Fremanezumab-A Humanized Monoclonal Anti-CGRP Antibody-Inhibits Thinly Myelinated (Aδ) But Not Unmyelinated (C) Meningeal Nociceptors.
Melo-Carrillo A; Strassman AM; Nir RR; Schain AJ; Noseda R; Stratton J; Burstein R
J Neurosci; 2017 Nov; 37(44):10587-10596. PubMed ID: 28972120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
